Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT03949920
Eligibility Criteria:
Inclusion Criteria:
Confirmed Fabry disease Aged 16 or over Beginning clinical treatment with Migalastat
Exclusion Criteria:
Contraindication to cardiac MRI
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT03949920
Study Brief:
Protocol Section:
NCT03949920